安捷伦USCAP 2026病理学更新深化肿瘤诊断叙事

FierceBiotechTakeda pivotal trial win improves convenience for PID patients relative to HyQvia

Endpoints NewsCelcuity breast cancer win; Odyssey plans $205M IPO; Latus Bio extends Series A

FierceBiotechWindward获1.65亿美元融资，推动长效TSLP研发雄心

Endpoints News生物科技迎来新型初创模式：小团队、高投资、中国资产

Thermo Fisher赛默飞世尔科技推出Gibco CTS DynaXS一次性生物反应器

PharmaVoiceArvinas获得里程碑式批准，蛋白质降解剂研发提速

Endpoints News风逸生物获1.65亿美元资金，将中国原研药推进哮喘三期临床试验

BioWorldBeijing Danatlas Pharmaceutical Technology prepares new PARG inhibitors

BioWorldShanghai Pharmaceuticals reports new FR-α-targeting ADCs

BioWorldSanyou Biopharmaceuticals discloses TROP2-targeting ADCs

BioWorldHoliday notice

BioWorldBeone eyes Huahui Health’s trispecific HH-160 with $2B option deal